Biotech Therapeutic Goods Administration Provisionally Approves Moderna’s Omicron-Containing Bivalent Booster Candidate, MRNA-1273.214, For Australia August 31, 2022
Biotech FibroGen Announces Completion of Patient Enrollment in MATTERHORN, a Phase 3 Clinical Study of Roxadustat for the Treatment of Anemia in Patients with Lower Risk Transfusion-Dependent Myelodysplastic Syndromes (MDS) August 29, 2022
Biotech Bionano Genomics Announces the First Publication Using OGM to Analyze Impact of Chromothripsis and TP53 Abnormalities on Chronic Lymphocytic Leukemia (CLL) Patients with High Genomic Complexity August 29, 2022
Biotech Travere Therapeutics to Present Abstracts at the Society for the Study of Inborn Errors of Metabolism Annual Symposium August 29, 2022
Biotech BioCryst Presents Data Demonstrating >99 Percent Suppression of Alternative Pathway Complement Activity with BCX9930 in C3G Patients August 29, 2022
Biotech Iovance Biotherapeutics Initiates Biologics License Application (BLA) Submission for Lifileucel in Advanced Melanoma August 29, 2022
Biotech ChemoCentryx Announces TAVNEOS® (avacopan) Presentations at Upcoming Medical Conferences August 29, 2022
Biotech CANCER Publishes Study Demonstrating Substantial Disease Burden for Patients with Systemic Mastocytosis August 29, 2022
Biotech U.S. Government Exercises Option to Purchase Additional RAPIVAB® (peramivir injection) from BioCryst for Pandemic Influenza Preparedness August 29, 2022
Biotech MAURICE icIEF ESTABLISHED AS A GREEN METHOD FOR CHARACTERIZATION OF AAV IDENTITY AND STABILITY August 29, 2022
Search
Biotech
August 31, 2022
August 29, 2022
August 29, 2022
August 29, 2022
August 29, 2022
August 29, 2022
August 29, 2022
August 29, 2022
August 29, 2022
August 29, 2022
